Skip to main content
. 2017 Sep 12;7:11380. doi: 10.1038/s41598-017-10440-9

Table 2.

Summary of the exome-array meta-analysis and replication results for markers with P < 1 × 10–4 in analysis including ‘All’ endometriosis cases. Chr, Chromosome; Genomic position is shown relative to GRCh37 (hg19); NS, nonsynonymous; EA, effect allele; NEA, non-effect allele; EAF, average effect allele frequency in the discovery cohorts; OR, odds ratio with respect to EA; CI, confidence interval; P het, P-value from heterogeneity test; P RE2, P-value from the Han Eskin random-effects (RE2) model.

Chr dbSNP ID Position (bp) Functional region Genes EA NEA Exome-array meta-analysis (all) deCODE replication (all) Total association analysis (all)
EAF OR (95% CI) P P het P RE2 OR (95% CI) P OR (95% CI) P P het P RE2
10 rs1801232 16870912 NS CUBN T G 0.08 0.82 (0.76–0.89) 7.47 × 10–7 0.25 0.95 (0.84–1.07) 0.37 0.86 (0.80–0.92) 4.18 × 10−6 0.09 5.97 × 10–6
2 rs6542095 113529183 intergenic IL1A T C 0.69 0.89 (0.85–0.94) 1.71 × 10–6 0.75 0.93 (0.86–1.01) 0.07 0.90 (0.87–0.94) 4.39 × 10−7 0.76
7 rs17172694 46437154 intergenic IGFBP3 T G 0.08 1.21 (1.11–1.30) 3.27 × 10−6 0.52 1.11 (0.99–1.25) 0.09 1.18 (1.10–1.26) 1.33 × 10−6 0.48
16 rs78108426 11001421 NS CIITA A C 0.01 1.87 (1.40–2.49) 1.90 × 10−5 0.07 2.40 × 10−5 0.34 (0.11–1.05) 0.06 1.68 (1.28–2.22) 2.31 × 10−4 0.004 6.99 × 10−5
10 rs138680811 98157006 NS TLL2 A G 0.003 2.44 (1.61–3.71) 2.72 × 10−5 0.40 1.96 (0.88–4.40) 0.10 2.33 (1.61–3.38) 7.49 × 10−6 0.53
2 rs17261772 135911422 synonymous RAB3GAP1 T C 0.74 0.88 (0.83–0.94) 3.33 × 10−5 0.0007 1.27 × 10−6 1.02 (0.91–1.14) 0.78 0.91 (0.86–0.96) 4.20 × 10−4 0.0002 3.87 × 10−6
10 rs12777823 96405502 intergenic CYP2C18 A G 0.15 1.13 (1.07–1.20) 3.39 × 10−5 0.15 0.99 (0.89–1.11) 0.88 1.10 (1.05–1.16) 3.08 × 10−4 0.05 1.58 × 10−4
4 rs4647930 1018705 NS FGFRL1 A C 0.27 0.90 (0.86–0.95) 3.98 × 10−5 0.10 1.04 (0.96–1.13) 0.31 0.94 (0.90–0.98) 2.83 × 10−3 0.004 3.27 × 10−4
16 rs1639150 3747204 intronic TRAP1 T C 0.43 0.91 (0.88–0.95) 4.25 × 10−5 0.92 1.04 (0.97–1.12) 0.32 0.94 (0.91–0.98) 2.54 × 10−3 0.09 1.61 × 10−3
17 rs2278868 46262171 NS SKAP1 T C 0.61 1.10 (1.05–1.14) 4.38 × 10−5 0.35 1.07 (1.00–1.16) 0.07 1.09 (1.05–1.13) 8.73 × 10−6 0.45
2 rs114242502 235951001 NS SH3BP4 A G 0.00 5.62 (2.45–12.89) 4.53 × 10−5 0.002 5.61 × 10−6 2.76 (0.07–115.4) 0.59 5.44 (2.42–12.22) 4.18 × 10−5 0.01 6.49 × 10−6
3 rs3772836 124535635 intronic ITGB5 A C 0.04 0.80 (0.72–0.89) 4.70 × 10−5 0.29 1.13 (0.96–1.34) 0.15 0.89 (0.81–0.97) 9.11 × 10−3 0.005 5.21 × 10−4
2 rs13394619 11727507 splicing GREB1 A G 0.48 0.92 (0.88–0.96) 5.77 × 10−5 0.61 0.83 (0.77–0.90) 7.43 × 10−7 0.89 (0.86–0.93) 2.33 × 10−9 0.17
9 rs512110 79320640 NS PRUNE2 T C 0.76 1.11 (1.05–1.16) 6.61 × 10−5 0.71 1.04 (0.95–1.13) 0.38 1.09 (1.04–1.14) 1.04 × 10−4 0.59
12 rs12313736 26383959 NS SSPN A G 0.04 1.25 (1.12–1.39) 6.73 × 10−5 0.70 1.05 (0.86–1.30) 0.63 1.20 (1.09–1.32) 1.67 × 10−4 0.53
6 rs9354308 66565353 intergenic SLC25A51P1 A G 0.63 0.91 (0.87–0.96) 6.88 × 10−5 0.94 0.92 (0.86–0.99) 0.03 0.92 (0.88–0.95) 6.69 × 10−6 0.98
10 rs12767583 96547463 intronic CYP2C19 T C 0.15 1.13 (1.06–1.20) 7.07 × 10−5 0.54 0.98 (0.88–1.10) 0.77 1.10 (1.04–1.15) 6.97 × 10−4 0.19
4 rs11131511 64933220 intergenic LPHN3-AS1 T G 0.54 1.09 (1.05–1.14) 7.24 × 10−5 0.30 0.95 (0.89–1.03) 0.21 1.05 (1.02–1.09) 6.08 × 10−3 0.01 1.08 × 10−3
2 rs1446585 136407479 intronic R3HDM1 A G 0.70 0.89 (0.84–0.94) 8.08 × 10−5 0.001 4.63 × 10−6 0.98 (0.89–1.09) 0.73 0.91 (0.87–0.96) 3.04 × 10−4 0.001 1.13 × 10−5
12 rs12313670 26383834 NS SSPN A G 0.04 1.24 (1.12–1.38) 8.42 × 10−5 0.75 1.05 (0.85–1.30) 0.63 1.20 (1.09–1.32) 1.96 × 10−4 0.59
10 rs1126545 96493058 NS CYP2C18 T C 0.15 1.13 (1.06–1.19) 8.51 × 10−5 0.60 0.98 (0.88–1.10) 0.76 1.09 (1.04–1.15) 8.53 × 10−4 0.21
22 rs148613283 18301508 NS MICAL3 T C 0.99 1.68 (1.29–2.17) 9.04 × 10−5 0.40 1.17 (0.68–2.01) 0.58 1.57 (1.24–1.98) 1.61 × 10−4 0.37